Ibrahim Aldoss

8.0k total citations
190 papers, 2.5k citations indexed

About

Ibrahim Aldoss is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Oncology. According to data from OpenAlex, Ibrahim Aldoss has authored 190 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 107 papers in Hematology, 101 papers in Public Health, Environmental and Occupational Health and 64 papers in Oncology. Recurrent topics in Ibrahim Aldoss's work include Acute Lymphoblastic Leukemia research (98 papers), Acute Myeloid Leukemia Research (54 papers) and Chronic Myeloid Leukemia Treatments (40 papers). Ibrahim Aldoss is often cited by papers focused on Acute Lymphoblastic Leukemia research (98 papers), Acute Myeloid Leukemia Research (54 papers) and Chronic Myeloid Leukemia Treatments (40 papers). Ibrahim Aldoss collaborates with scholars based in United States, Brazil and Italy. Ibrahim Aldoss's co-authors include Vinod Pullarkat, Stephen J. Forman, Anthony S. Stein, Guido Marcucci, Dan Douer, Ryotaro Nakamura, Joo Y. Song, Apar Kishor Ganti, Joycelynne Palmer and Tsewang Tashi and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Ibrahim Aldoss

172 papers receiving 2.5k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Ibrahim Aldoss 1.1k 1.0k 899 550 466 190 2.5k
Margaret O’Donnell 2.2k 1.9× 884 0.8× 1.1k 1.2× 607 1.1× 291 0.6× 91 3.4k
Mar Tormo 2.1k 1.8× 1.0k 1.0× 646 0.7× 1.3k 2.4× 321 0.7× 106 3.1k
Katsuyoshi Koh 933 0.8× 998 1.0× 409 0.5× 351 0.6× 558 1.2× 180 2.0k
André Schrauder 1.9k 1.7× 2.1k 2.0× 770 0.9× 562 1.0× 929 2.0× 77 3.3k
Ken Bradstock 987 0.9× 759 0.7× 496 0.6× 269 0.5× 223 0.5× 35 1.7k
Michael Potter 1.8k 1.5× 760 0.7× 767 0.9× 710 1.3× 263 0.6× 116 3.3k
Birgitte Lausen 1000 0.9× 790 0.8× 426 0.5× 388 0.7× 390 0.8× 84 1.7k
Henry C. Fung 839 0.7× 371 0.4× 790 0.9× 309 0.6× 182 0.4× 99 2.1k
Giuseppe Milone 2.2k 1.9× 553 0.5× 851 0.9× 1.2k 2.1× 143 0.3× 142 3.2k
Ian M. Franklin 2.0k 1.8× 1.4k 1.3× 814 0.9× 432 0.8× 438 0.9× 77 3.3k

Countries citing papers authored by Ibrahim Aldoss

Since Specialization
Citations

This map shows the geographic impact of Ibrahim Aldoss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ibrahim Aldoss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ibrahim Aldoss more than expected).

Fields of papers citing papers by Ibrahim Aldoss

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ibrahim Aldoss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ibrahim Aldoss. The network helps show where Ibrahim Aldoss may publish in the future.

Co-authorship network of co-authors of Ibrahim Aldoss

This figure shows the co-authorship network connecting the top 25 collaborators of Ibrahim Aldoss. A scholar is included among the top collaborators of Ibrahim Aldoss based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ibrahim Aldoss. Ibrahim Aldoss is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chin, Kuo‐Kai, Brian Ball, Yasmin Abaza, et al.. (2025). Outcomes of relapsed or refractory acute myeloid leukemia after menin inhibition failure. Blood Advances. 10(5). 1537–1547.
2.
Wong, Jeffrey Y.C., Amandeep Salhotra, Savita Dandapani, et al.. (2024). Phase II Trial of TMLI 20 Gy in Combination with Cyclophosphamide and Etoposide in Patients with Poor-Risk Acute Leukemia. International Journal of Radiation Oncology*Biology*Physics. 120(2). S90–S91.
3.
Ghobadi, Armin, Ibrahim Aldoss, Shannon L. Maude, et al.. (2024). Phase 1/2 Dose-Escalation/Dose-Expansion Study of Anti-CD7 Allogeneic CAR-T Cells (WU-CART-007) in Relapsed or Refractory (R/R) T-Cell Acute Lymphoblastic Leukemia/ Lymphoblastic Lymphoma (T-ALL/LBL). Transplantation and Cellular Therapy. 30(2). S14–S15. 1 indexed citations
4.
Otoukesh, Salman, et al.. (2024). Blinatumomab-induced macrophage activating syndrome (MAS) in adult with B-cell acute lymphoblastic leukemia (B-ALL). Annals of Hematology. 103(7). 2541–2543.
5.
Zhang, Jianying, Vinod Pullarkat, Vaibhav Agrawal, et al.. (2024). Therapy‐related acute lymphoblastic leukaemia in women with antecedent breast cancer. British Journal of Haematology. 205(1). 158–165. 1 indexed citations
6.
Agrawal, Vaibhav, et al.. (2023). Positioning blinatumomab in the frontline of adult B-cell acute lymphoblastic leukemia treatment. Frontiers in Oncology. 13. 1237031–1237031. 10 indexed citations
7.
Aldoss, Ibrahim, Josep‐María Ribera, Hagop M. Kantarjian, et al.. (2023). Ponatinib Versus Imatinib in Patients with Newly Diagnosed Ph+ ALL: Subgroup Analysis of the Phase 3 Phallcon Study. Blood. 142(Supplement 1). 2871–2871. 2 indexed citations
8.
Rosa, Corinna La, Ibrahim Aldoss, Dongyun Yang, et al.. (2023). CMV-MVA Triplex Vaccination of Stem Cell Donors to Enhance CMV Specific Immunity and Prevent CMV Viremia in Recipients after Stem Cell Transplant. Transplantation and Cellular Therapy. 29(2). S68–S69. 1 indexed citations
9.
10.
Rosa, Corinna La, Flavia Chiuppesi, Alfredo Puing, et al.. (2022). Successful outcome of pre-engraftment COVID-19 in an HCT patient: impact of targeted therapies and cellular immunity. Blood Advances. 6(6). 1645–1650. 3 indexed citations
11.
Malki, Monzr M. Al, Joycelynne Palmer, Ni‐Chun Tsai, et al.. (2022). Total marrow and lymphoid irradiation as conditioning in haploidentical transplant with posttransplant cyclophosphamide. Blood Advances. 6(14). 4098–4106. 15 indexed citations
12.
Malki, Monzr M. Al, Ni‐Chun Tsai, Joycelynne Palmer, et al.. (2021). Posttransplant cyclophosphamide as GVHD prophylaxis for peripheral blood stem cell HLA-mismatched unrelated donor transplant. Blood Advances. 5(12). 2650–2659. 32 indexed citations
13.
Nelson, Rebecca A., Ibrahim Aldoss, Vinod Pullarkat, et al.. (2021). Immunophenotype of acute lymphoblastic leukemia in minorities‐ analysis from the SEER database. Hematological Oncology. 40(1). 106–111. 3 indexed citations
14.
15.
Yao, Janny M., Dongyun Yang, Mary C. Clark, et al.. (2021). Tacrolimus initial steady state level in post-transplant cyclophosphamide-based GvHD prophylaxis regimens. Bone Marrow Transplantation. 57(2). 232–242. 3 indexed citations
16.
Zhao, Yaqi, Ibrahim Aldoss, Chunxu Qu, et al.. (2020). Tumor-intrinsic and -extrinsic determinants of response to blinatumomab in adults with B-ALL. Blood. 137(4). 471–484. 77 indexed citations
17.
Aldoss, Ibrahim, Jianying Zhang, Matthew Mei, et al.. (2020). Venetoclax and hypomethylating agents in FLT3‐mutated acute myeloid leukemia. American Journal of Hematology. 95(10). 1193–1199. 27 indexed citations
18.
19.
20.
Rosa, Corinna La, Jeff Longmate, Joy Martinez, et al.. (2016). MVA vaccine encoding CMV antigens safely induces durable expansion of CMV-specific T cells in healthy adults. Blood. 129(1). 114–125. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Margaret O’Donnell Breakdown of academic impact, for papers by Mar Tormo Breakdown of academic impact, for papers by Katsuyoshi Koh Breakdown of academic impact, for papers by André Schrauder Breakdown of academic impact, for papers by Ken Bradstock Breakdown of academic impact, for papers by Michael Potter Breakdown of academic impact, for papers by Birgitte Lausen Breakdown of academic impact, for papers by Henry C. Fung Breakdown of academic impact, for papers by Giuseppe Milone Breakdown of academic impact, for papers by Ian M. Franklin
Rankless by CCL
2026